P53 protein expression in lymphomas and reactive lymphoid tissue

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The p53 gene, a tumor suppressor on chromosome 17, regulates cell growth and S-phase entry.
• p53 mutations are increasingly found in human malignancies.
• Elevated nuclear p53 protein, detectable by immunohistochemistry, indicates stabilization in tumors.

Purpose of the Study:

• To investigate the correlation between p53 protein levels and lymphoma aggressiveness.
• To quantify p53 protein expression in various lymphoma subtypes and normal tissues.

Main Methods:

• Immunohistochemistry using monoclonal antibody PAb 1801 to detect nuclear p53 protein.
• Image analysis system for quantifying p53 protein levels.
• Analysis of 83 non-Hodgkin's lymphomas (NHLs), 13 Hodgkin's disease cases, and 14 normal/reactive lymphoid tissues.

Main Results:

• High p53 protein levels (>5% of cells) were predominantly found in high-grade lymphomas (13/55), notably Burkitt's lymphoma (5/8).
• Lower p53 levels (<5%) were observed in low-grade B- and T-cell lymphomas and most Hodgkin's disease cases.
• p53 protein was selectively present in Hodgkin and Reed-Sternberg cells in Hodgkin's disease; occasional positive cells found in reactive tissues.

Conclusions:

• p53 protein levels appear to be related to the aggressiveness of non-Hodgkin's lymphomas.
• The study highlights the potential role of p53 as a biomarker for lymphoma grading.